Keyphrases
Kidney Transplant Recipients
49%
Kidney Transplantation
39%
Kidney
37%
Renal Transplant
30%
Kidney Transplant
25%
Immune Response
22%
Self-antigens
20%
Transplantation
20%
Transplant Recipients
19%
Single Center
18%
Acute Rejection
17%
Simultaneous Pancreas-kidney Transplant
13%
Confidence Interval
13%
Human Leukocyte Antigen
12%
Tacrolimus
12%
Adult Kidney
12%
Transplant Population
12%
Renal Transplantation
12%
Allograft
12%
Solid Organ Transplant Recipients
11%
Retrospective Cohort Study
11%
End-stage Renal Disease
11%
Cystinosis
10%
Cropping Pattern
10%
Small Farm Reservoir
10%
Rainfed Lowland
10%
Heavy Proteinuria
10%
Calcineurin Inhibitor Withdrawal
10%
Prolonged-release Tacrolimus
10%
Eculizumab
10%
Cytomegalovirus
10%
Focal Segmental Glomerulosclerosis
10%
Thrombotic Microangiopathy
10%
Reductase Inhibitors
10%
3-hydroxy-3-methylglutaryl-CoA Reductase
10%
Rituximab
10%
Editorial Team
10%
Organ Allocation
10%
Older Adults
10%
Treatment Refractory
10%
Quiescence
10%
HLA Matching
10%
Sitagliptin
10%
Allosensitization
10%
Immune Quiescence
10%
Hyperparathyroidism
10%
Randomized Double-blind Controlled Trial
10%
Chronic Kidney Disease Patients
10%
Obesity
10%
Adult Kidney Transplant Recipients
10%
Medicine and Dentistry
Kidney Graft
100%
Transplantation
50%
Kidney Transplantation
36%
Tacrolimus
23%
Allograft
18%
Graft Failure
14%
Acute Kidney Injury
14%
End Stage Renal Disease
13%
Retrospective Study
11%
Cytomegalovirus
11%
Calcineurin Inhibitor
11%
Immunosuppressant
11%
Retrospective Cohort Study
11%
Cystinosis
10%
Proteinuria
10%
Chimeric Antigen Receptor T-Cell Immunotherapy
10%
Organ Transplantation
10%
Focal Segmental Glomerulosclerosis
10%
Posttransplant Lymphoproliferative Disease
10%
Diabetes Mellitus
10%
Prospective Study
10%
Antivirus Agent
10%
Haplotype
10%
Placebo
10%
Cardiovascular Risk
10%
Sitagliptin
10%
Hemodialysis
10%
Rituximab
10%
Hyperparathyroidism
10%
Kidney Pancreas Transplantation
10%
Eculizumab
10%
Glomerulonephritis
10%
Single Drug Dose
10%
Graft Versus Host Reaction
10%
Myocardial Disease
10%
Thrombotic Thrombocytopenic Purpura
10%
Bone Disease
10%
Cardiovascular System
9%
Chronic Kidney Disease
8%
Immunosuppressive Treatment
8%
Acute Graft Rejection
7%
Oral Glucose Tolerance Test
6%
Arm
6%
Solid Organ Transplantation
6%
Thymocyte Antibody
6%
Renal Replacement Therapy
6%
Viremia
5%
Programmed Death 1 Receptor
5%
Body Mass Index
5%
Chimeric Antigen Receptor T-Cell
5%
